- Home
- Advocacy
- Latest News and Practice Data
- Coalition urges Congress to boost CDC genomic surveillance funding
A coalition of medical, public health, academic, and industry organizations is urging Congress to increase funding for the CDC’s Advanced Molecular Detection (AMD) program in 2027.
Zoom in: In an April 2 letter, the groups requested $175 million annually for the CDC program, supporting genomic sequencing and advanced data analytics for infectious disease surveillance.
The AMD program enables health departments to detect and track infectious diseases using genomic sequencing.
- It’s crucial for foodborne outbreak investigations, influenza surveillance, wastewater monitoring, and antimicrobial-resistant infection responses.
- It supports pathogen genomics training and regional centers connecting research with public health practice.
Current supplemental funding is set to expire in 2027.
The impact: The coalition warns that without increased funding, genomic surveillance capacity could weaken.
- Outbreak detection and response times could suffer.
- US preparedness for emerging infectious disease threats would decline as new risks rise.